1521 - Real-world efficacy and safety of venetoclax +/- rituximab in >75-years old patients or with cardiovascular comorbidities and R/R chronic lymphocytic leukemia: interim results of the VERONE study

Professor of Hematology
IUCT Oncopole
Toulouse, Midi-Pyrenees, France

Professeur Émérite
Caen University Hospital
Caen, France

head
Hôpital Avicenne, Département de Recherche Clinique, INSERM U1432, Hôpital Saint Louis
Bobigny, France

Hospital Center, Quimper, France
Quimper, Bretagne, France

MD
CH Le Mans
Le Mans, France

MD
Centre Henri Becquerel
Rouen, France

Head of the Hematology Department
Léon Bérard Cancer Center in Lyon (CLB)
Lyon, France

Pitié-Salpêtrière Hospital
Paris, France

MD
CHU nancy
Nancy, France

Abbvie France
Rungis, Ile-de-France, France

Medical Advisor CLL
Abbvie France
Rungis, Ile-de-France, France

Professor of Hematology
CHU Clermont-Ferrand
Université Clermont Auvergne
Clermont-Ferrand, France